Single Patient Study to Treat Relapsing Polychondritis With Tocilizumab

NCT01041248 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

1

Enrollment

OTHER

Sponsor class

Conditions

Relapsing Polychondritis

Interventions

DRUG: Tocilizumab

Sponsor

Children's Hospital of Eastern Ontario